[1]
“An Explorative Study of Oral Microemulsion-based Formulation for the Delivery of Cabazitaxel and Piperine”, Int. J. Pharm. Sci. Drug Res., vol. 14, no. 3, pp. 351–357, May 2022, doi: 10.25004/IJPSDR.2022.140307.